November/December 2015

Biopharma Asia

November/December 2015 | Volume 4 Issue 6


Shortening Timelines for Upstream Bioprocessing of Protein-based Therapeutics

By: Dr Jincai Li, Executive Director, Biologics Process Development, Wuxi AppTec, China....


Current Developments with Disposable Technology and Single-Use Systems for Aseptic Process...

By: Tim Sandle, Head of Microbiology BPL


What is holding Industry back from Implementing Continuous Processing: Can Asia Adopt Mor...

By: Morten Munk, Senior Technology Partner Global Business Development, NNE Pharmaplan, Ge...


Culture of Pharmaceutical Quality: Improving Quality Management System

By: Ajaz S. Hussain, Ph.D. Insight Advice and Solutions LLC. Frederick, MD 21702, USA*, an...


Use of cyclodextrin to achieve a taste masked, bioequivalent Cetirizine HCl 10mg Zydis® d...

By: L. Grother, K. Hau, P. Axe, J.F. Baker Catalent


Neusilin®-Polymer Extrudates for the Development of Amorphous Solid Dispersions

University of Greenwich


SYLOID® XDP Silica: Optimised for Liquisolid and Lipid-based Formulations

Grace


Development and evaluation of a research screening assay to elucidate potential endogenous...

By: Randall Logan1, Sirantha Perera1, J.D. Pipkin2 and Jeffrey P. Krise1,* Captisol 1Depar...


Improvement of Physical Stability of Soft Gelatin Capsules by Film Coating

By: Yinqi Zhou and Irena McGuffy Catalent